Skip to content

THE HUMAN APEX · Human Optimization. Train With Intent. Fuel With Intelligence. Recover With Purpose. Build A Resilient Mind. Understand Longevity. Turn Knowledge Into Action. One Human · One Connected System.

Research area

Longevity & Healthy Aging Research

Examines pathways associated with cellular ageing in laboratory models: NAD+ availability to sirtuins and PARPs, telomerase regulation, and copper-dependent gene expression.

Compound classes
3Compound classes
Randomised human trials
39Randomised human trials
Field references
12Field references
Last retrieved
2026-08-03Last retrieved

Read at your level

The standard reading.

Longevity research studies the biological processes that change with age, and asks which of them actually drive ageing rather than simply accompany it. The framework the field uses to organise them — commonly called the hallmarks of ageing — sorts those processes into categories such as genomic instability, telomere shortening (attrition), mitochondrial dysfunction, and cellular senescence.

Peptide and small-molecule research enters this field mostly through metabolism and signalling: how much NAD+ is available to the enzymes that repair DNA and regulate gene expression, the pathways that influence whether damaged cells are cleared away or linger, and signals associated with tissue maintenance.

Significance

Why this area is studied

Ageing is the largest single risk factor for most chronic disease, so a mechanism that genuinely modified it would matter enormously. That is precisely why this field attracts both serious science and extravagant marketing, and why the distance between a mechanism demonstrated in cells and an outcome demonstrated in people deserves more attention here than almost anywhere else in peptide research.

Mechanism

The science, in plain terms

Cellular senescence

Cells that stop dividing but refuse to die accumulate with age and secrete inflammatory signals into surrounding tissue. Reviews in Nature Reviews Molecular Cell Biology and Physiological Reviews describe this state as both protective — it prevents damaged cells replicating — and harmful when it persists.

NAD+ as a shared substrate

NAD+ is consumed by sirtuins and PARPs, enzymes involved in DNA repair and the regulation of gene expression. Tissue levels decline with age, which is the observation the entire precursor field is built on. That the decline is real is well documented; that reversing it changes outcomes is not.

Telomere biology

Chromosome ends shorten with each division until a cell can no longer divide safely. Telomerase can extend them, which is why compounds reported to influence its expression attract attention — and also why they warrant caution, since the same mechanism is relevant to how tumours evade that limit.

Practice

How the research is conducted

The study designs that generate evidence in this area. Each carries its own interpretive limits — which is why the evidence hierarchy is worth reading alongside them.

  1. 01

    Replicative and stress-induced senescence assays in cultured human cells

  2. 02

    Lifespan and healthspan studies in short-lived model organisms

  3. 03

    Measurement of NAD+ and its metabolites in blood and tissue before and after intervention

  4. 04

    Epigenetic and biomarker panels used as surrogate measures of biological age

Open questions

What researchers are still testing

These are questions under investigation, not expected outcomes. Listing them is a description of where the field’s attention currently sits — not a suggestion that any of them will resolve favourably.

  1. 01

    Whether raising NAD+ levels — which oral precursors reliably do — produces any change in a clinical outcome, as opposed to a change in the biomarker itself

  2. 02

    Whether surrogate measures of biological age track anything that matters over a human lifespan

  3. 03

    Whether compounds reported to influence telomerase in cell culture do so in an intact organism, and what the consequences would be if they did

Constraints

Limitations worth holding onto

This field has one of the widest gaps in peptide science between mechanistic plausibility and human evidence. Several compounds studied here have substantial laboratory literature and no randomised human trials at all.

Surrogate markers are the recurring difficulty. Moving a biomarker associated with ageing is not the same as slowing ageing itself, and a study that measures the first cannot demonstrate the second — a distinction routinely collapsed when these findings are reported outside the scientific literature.

Index

Compound classes in this area

Sources

References for this field

Review articles covering the area as a whole, retrieved from PubMed. The explanatory sections above summarise what work of this kind reports.

Catalogue category →

This is a bibliographic and educational resource for research professionals. It is not medical, clinical, or legal advice, and nothing here is a recommendation to use any compound. Peptide research is an evolving field: what the literature contains changes as new work is published. Readers are responsible for evaluating the primary sources themselves and for consulting qualified professionals in their own jurisdiction.

← The research library